/PRNewswire/ RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led by Notation Capital and Divergent.
Arpeggio Biosciences raised $17 million in a Series A funding round led by Builders VC. The startup is focused on measuring the transcriptome which refers to the full range of mRNA molecules expressed by an organism to develop better therapeutics.